Citi’s Levkovich on AbbVie, Allergan Deal

Jun.25 — AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan Plc. Tobias Levkovich, chief U.S. equity strategist at Citi, discusses on “Bloomberg Surveillance.”